Access cutting-edge loss of appetite treatment through this clinical trial at a research site in Peoria. Study-provided care at no cost to qualified participants.
Access loss of appetite specialists in Peoria at no cost
This study follows strict safety protocols and ethical guidelines
All study-related loss of appetite treatment provided free
This phase III trial compares the effects of olanzapine versus megestrol acetate in treating loss of appetite in patients with cancer that has spread to other places in the body (advanced). Olanzapine may stimulate and increase appetite. This study aims to find out if olanzapine is better than the usual approach (megestrol acetate) for stimulating appetite and preventing weight loss.
Sponsor: Alliance for Clinical Trials in Oncology
Check if you qualify for this loss of appetite clinical trial in Peoria, AZ
If you're searching for loss of appetite treatment options in Peoria, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Peoria research site is actively enrolling participants for this clinical trial. You'll receive care from experienced loss of appetite specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.